BTK and B-cell chronic lymphocytic leukemia: We evaluated the ability of reversible covalent (RC-2), irreversible covalent (IR-2) and reversible non-covalent (NC-1) compounds (Supplementary Figure 1) to induce BTK degradation in CLL cell.